Preclinical Evaluation of Invariant Natural Killer T Cells in the 5T33 Multiple Myeloma Model-Reference-Cited by-同舟云学术

Preclinical Evaluation of Invariant Natural Killer T Cells in the 5T33 Multiple Myeloma Model

Published:2013-05-31 Issue:5 Volume:8 Page:e65075
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Nur Haneen,Fostier Karel,Aspeslagh Sandrine,Renmans Wim,Bertrand Elisabeth,Leleu Xavier,Favreau Mérédis,Breckpot Karine,Schots Rik,De Waele Marc,Van Valckenborgh Els,De Bruyne Elke,Facon Thierry,Elewaut Dirk,Vanderkerken Karin,Menu Eline

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. Harnessing CD1d-restricted T cells toward antitumor immunity in humans;N Neparidze;Ann N Y Acad Sci,2009

2. The NKT cell system: bridging innate and acquired immunity;M Taniguchi;Nat Immunol,2003

3. Natural killer T cells and autoimmune disease;L Wu;Curr Mol Med,2009

4. Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide;HJ Bontkes;Clin Immunol,2010

5. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities;L Wu;Tissue Antigens,2009

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. invariant Natural Killer T cell therapy as a novel therapeutic approach in hematological malignancies;Frontiers in Transplantation;2024-05-06

2. Laboratory Mice – A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma;Frontiers in Immunology;2021-06-02

3. Actors on the Scene: Immune Cells in the Myeloma Niche;Frontiers in Oncology;2020-10-29

4. Navigating the Role of CD1d/Invariant Natural Killer T-cell/Glycolipid Immune Axis in Multiple Myeloma Evolution: Therapeutic Implications;Clinical Lymphoma Myeloma and Leukemia;2020-06

5. Immunotherapeutics in Multiple Myeloma: How Can Translational Mouse Models Help?;Journal of Oncology;2019-04-10